![An illustration of a brain with stroke symptoms](https://www.uc.edu/news/articles/2025/01/n21305244/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1738165697125.jpg)
AHA advisory endorses EVT for large-core ischemic stroke
UC expert comments on new recommendations to Medscape
The University of Cincinnati's Pooja Khatri spoke with Medscape on a new American Heart Association advisory recommending endovascular therapy (EVT) as a treatment for patients with large-core ischemic strokes.
The advisory was published Dec. 17 in the journal Stroke, and Khatri was a coauthor.
EVT is a minimally invasive procedure for acute ischemic stroke patients that uses a catheter to remove a clot from a blood vessel in the brain, which restores blood flow. Patients with strokes with a large ischemic core were previously not considered candidates for EVT because of concerns of an increased risk of hemorrhage, disability and death, but six recent trials provided evidence of its benefit.
“These trials provide new data to suggest that selected patients with ischemic stroke due to large vessel occlusions should be treated with EVT,” Khatri, MD, vice chair of research and division chief in the Department of Neurology and Rehabilitation Medicine at UC's College of Medicine; associate director of the UC Gardner Neuroscience Institute; and codirector of NIH StrokeNet’s National Coordinating Center, told Medscape.
“These findings ran counter to prior thinking and guidelines, so we wanted to bring this important treatment opportunity to the attention of practicing clinicians," she added.
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
UC marks 4 years saving lives with mobile stroke unit
August 15, 2024
![Local 12 logo](/content/dam/refresh/uc-news/news-icons/dark/wkrc-logo-dark.png)
The University of Cincinnati's Christopher Richards spoke with Local 12 about the four-year anniversary of the mobile stroke unit that can bring the emergency department directly to patients.
Trial finds new drug safe, effective to treat deadliest form of epilepsy
October 23, 2024
![MSN logo](/content/dam/refresh/uc-news/news-icons/dark/msn.png)
MSN highlighted research presented by the University of Cincinnati’s Brandon Foreman that found ganaxolone is a safe and effective treatment for refractory status epilepticus.
WLWT: UC hosts RESET epilepsy trial
May 3, 2023
WLWT spoke with the University of Cincinnati's Brandon Foreman about a clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.